Physician profile
Amy Thompson
NPI 1306288485
$11,230.00
in general payments reported to CMS, 2019-2025
40 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,063 · 2022: $2,157 · 2023: $2,328 · 2024: $2,392 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,999 · Consulting Fee: $11.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,999.07 |
| Consulting Fee | $11.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,638.79 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $2,034.20 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $969.70 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $927.42 | 2021-2025 | Dupixent |
| Pfizer INC. | $646.25 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $614.74 | 2021-2025 | Takhzyro, Cuvitru, Eohilia |
| Csl Behring | $409.07 | 2023-2025 | Hizentra, Haegarda, Andembry |
| Biocryst US Sales Co., LLC | $346.81 | 2021-2025 | Orladeyo |
| Amgen INC. | $303.39 | 2021-2025 | Tezspire |
| Kaleo, INC. | $264.15 | 2021-2024 | Auvi-Q |
| Alk-Abello, INC | $254.57 | 2021-2022 | |
| Pharming Healthcare, INC. | $230.40 | 2021-2025 | Ruconest |
| Leo Pharma INC. | $183.11 | 2022-2023 | Adbry |
| Genentech USA, INC. | $157.39 | 2021-2024 | Xolair |
| Novartis Pharmaceuticals Corporation | $113.06 | 2024-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.